Piclidenoson

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe SyndromeNCT07410455Can-Fite BioPharmaPhase 2Not yet recruiting2027-08-31Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.